vimarsana.com

Page 385 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Role of AI in Addressing the Maternal Health Crisis

Over 800 women died from pregnancy-related complications in 2020 in the United States, and well over half of these deaths were preventable. This isn’t news for professionals who work in this space because maternal deaths in the U.S. outnumber those in most industrialized nations in the west. Maternal outcomes for Black women in the US are even worse. Black mothers die from pregnancy-related complications nearly three times more frequently than white and Hispanic women. Despite efforts to prioritize improved maternal mortality, there’s been very little progress. In fact, maternal mortality actually increased over 18% between 2019 and 2020. Much of this increase is a result of the Covid-19 pandemic. For excess deaths that aren’t attributable to complications from Covid-19, technology may hold the solution. Artificial Intelligence may improve maternal health outcomes in the US Many tech companies focused on developing and implementing AI-driven solutions to healthcare problems in t

Don t Be Creepy : How Health Systems Can Help Build Patients Trust in New Tech

As health systems roll out new patient-facing technologies, they need to ensure that their patients are comfortable using these tools. To avoid losing patient trust, hospitals should introduce new technology with transparency and patient education at the forefront of their minds, said Aaron Miri, Baptist Health's chief digital and information officer.

Stop, Drop and Reenroll: How Medicaid Redeterminations, Renewals, and Disenrollment Can Affect the Revenue Cycle

Patient Deaths and Partial Hold Prompt Gossamer Bio to Stop Work on Cancer Drug

Two fatalities were reported in an early-stage study testing a Gossamer Bio drug intended to treat a rare cancer affecting the central nervous system. Due to the adverse events and a partial FDA clinical hold, Gossamer has decided to stop work on the program.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.